Black Knight selling unit to win clearance for acquisition by IntercontinentalExchange

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Österreich Nachrichten Nachrichten

Österreich Neuesten Nachrichten,Österreich Schlagzeilen

Black Knight Inc. and Intercontinental Exchange Inc. cut the value of their merger deal by about $1.4 billion on Tuesday after Black Knight said it’s selling...

Black Knight Inc. BKI and Intercontinental Exchange Inc. ICE cut the value of their merger deal by about $1.4 billion on Tuesday after Black Knight said it’s selling its Empower loan origination system to Constellation Software Inc. CA:CSU to win clearance for its deal with ICE with U.S. regulators. Black Knight did not provide a purchase price for its Empower loan origination system, which includes Exchange, LendingSpace and Aiva solutions.

4 billion on Tuesday after Black Knight said it’s selling its Empower loan origination system to Constellation Software Inc. CSU to win clearance for its deal with ICE with U.S. regulators. Black Knight did not provide a purchase price for its Empower loan origination system, which includes Exchange, LendingSpace and Aiva solutions. The companies said the deal is partly to secure clearance of ICE’s proposed acquisition of Black Knight under the Hart-Scott Rodino Act.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 3. in AT
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsShares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »